UPDATE 1-Abbott sales beat as demand for generic drugs rises

Oct 21 (Reuters) - Abbott Laboratories Inc reported better-than-expected quarterly sales as demand rose for its generic drugs in emerging markets, including Latin America and China.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.